| Literature DB >> 30258498 |
Anja Müller1, Wiebke Jansen1,2, Nils Th Grabowski1, Corinna Kehrenberg1.
Abstract
BACKGROUND: Food products of animal origin brought into the EU from third countries, both legally and illegally, can harbor foodborne pathogens such as Salmonella enterica. In this study, we examined five S. enterica isolates recovered either from legally imported chicken meat (n = 3) or from meat products confiscated from air travel passengers arriving in Germany (n = 2). The isolates were serotyped and further characterized by antimicrobial susceptibility testing, PCR-detection and sequencing of genes associated with antimicrobial resistances, and macrorestriction analysis. Transferability of resistance to third-generation cephalosporins was assessed by conjugation experiments and the plasmids tested for their incompatibility groups.Entities:
Keywords: AmpC-β-lactamase; Antimicrobial resistance; Illegal import; Legal import; Meat products; Salmonella enterica
Year: 2018 PMID: 30258498 PMCID: PMC6151051 DOI: 10.1186/s13099-018-0268-3
Source DB: PubMed Journal: Gut Pathog ISSN: 1757-4749 Impact factor: 4.181
Fig. 1Typing results, resistance phenotypes and genotypes of the five Salmonella isolates. aOnly antimicrobial agents for which CLSI-approved MIC breakpoints are available, are included. BLA β-lactams, CHL chloramphenicol, CIP ciprofloxacin, GEN gentamicin, NAL nalidixic acid, SMX sulfamethoxazole, TET tetracycline, TMP trimethoprim, brackets indicate intermediate resistance
Fig. 2Plasmid profiles of HK225 transconjugants, run in a 1% agarose gel and stained with ethidium bromide. AmpC-producing Salmonella enterica isolates were used as donor strains. The 94 kb plasmid of S. Typhimurium strain LT2 served as size marker. Chr residues of chromosomal DNA
Characteristics and comparison of AmpC-producing Salmonella donor strains and Escherichia coli transconjugants
| Isolate | Resistance genes | Inc. group of transferred Plasmid | Resistance phenotype | MIC values (µg/ml) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMP | AMC | CTX | CAZ | NAL | CIP | SMX | TET | ||||
| 253 | IncA/C | BLA, NAL, (CIP), SMX, TET | > 64 | > 32/16 | > 4 | > 8 | > 128 | 0.5 | > 1024 | > 64 | |
| TC253 (HK225 transconjugant) | BLA, SMX, TET | > 64 | > 32/16 | > 4 | > 8 | 8 | 0.06 | >1024 | 32 | ||
| 300 | IncI1 | BLA, NAL, CIP, SMX, TET | > 64 | > 32/16 | > 4 | > 8 | > 128 | 1 | > 1024 | > 64 | |
| TC300 (HK225 transconjugant) |
| BLA | > 64 | > 32/16 | > 4 | > 8 | 8 | 0.06 | 32 | ≤ 2 | |
| 417 | IncA/C | BLA, NAL, CIP, SMX, TET | > 64 | > 32/16 | > 4 | > 8 | > 128 | 1 | > 1024 | > 64 | |
| TC417 (HK225 transconjugant | BLA, SMX, TET | > 64 | > 32/16 | > 4 | > 8 | 8 | 0.06 | >1024 | 32 | ||
| – | – | – | 2 | ≤ 2/1 | ≤ 0.25 | ≤ 0.5 | 8 | 0.06 | 32 | ≤ 2 | |
AMC amoxicillin/clavulanate (2:1), AMP ampicillin, BLA β-lactams, CAZ ceftazidime, CIP ciprofloxacin, CTX cefotaxime, NAL nalidixic acid, SMX sulfamethoxazole, TET tetracycline